|
Few relapse if HCV response is sustained 6 mos after therapy. (Pegylated Interferon Alfa-2b).(hepatitis C virus)
Publication: Internal Medicine News Publication Date: 15-FEB-02 Author: Demott, Kathryn
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2002 International Medical News Group
DALLAS -- Less than 5% of chronic hepatitis C patients relapse if they still have a sustained virologic response to pegylated interferon alfa-2b at 6 months after they stop treatment, Dr. John McHutchison said at the annual meeting of the American Association for the Study of Liver Diseases.
Dr. McHutchison of the Scripps...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Internal Medicine News |
Pegylated interferon alfa-2b, ribavirin best against fibrosis. (Out of...
February 15, 2002
|
Lyme disease vaccine not tied to arthritis risk. (Preliminary Data).
February 15, 2002
|
Lyme disease nearly doubled in 10 years. (Increased 8% Since 1999).(St...
February 15, 2002
|
Adefovir reduces fibrosis in precore mutant HBV. (Strain Does Not Prod...
February 15, 2002
|
RA, SLE, and Pneumococcus. (Clinical Capsules).(rheumatoid arthritis, ...
February 15, 2002
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
